After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Arbutus Biopharma Corp is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Arbutus Biopharma Corp is $627.21M. A total of 0.59 million shares were traded on the day, compared to an average of 872.71K shares.
In the most recent transaction, Sofia Michael J. bought 150,000 shares of ABUS for 3.20 per share on Mar 19 ’25. In a previous transaction on Mar 13 ’25, Sofia Michael J. bought 100,000 shares at 3.38 per share.
Among the insiders who bought shares, Sofia Michael J. acquired of 167,162 shares on Mar 07 ’25 at a per-share price of $3.29. In another insider transaction, HASTINGS DAVID C sold 22,183 shares at $3.28 per share on Feb 04 ’25. Company shares held by the Chief Financial Officer now total 159,724.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ABUS has a high of $4.72 and a low of $2.30.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ABUS’s latest balance sheet shows that the firm has $155.32M in Cash & Short Term Investments as of fiscal 2021. There were $2.61M in debt and $11.22M in liabilities at the time. Its Book Value Per Share was $0.56, while its Total Shareholder’s Equity was $169.44M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ABUS is Buy with a score of 4.50.
